Literature DB >> 2223649

The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction.

F Pezzella1, E Ralfkiaer, K C Gatter, D Y Mason.   

Abstract

The 14;18 chromosomal translocation is widely recognized as a cytogenetic abnormality associated with follicular lymphomas, but estimates of its frequency in this type of lymphoma vary widely from less than 50% to almost 90%. Furthermore, no extensive data have been published on the frequency of t(14;18) in European cases of follicular lymphoma. Lymph nodes from 51 patients with follicular lymphomas obtained from two European centres (Oxford and Copenhagen) were examined for the presence of this translocation. Southern blotting and the polymerase chain reaction (PCR) were used in 26 cases and the PCR alone in 25 cases (from which only degraded DNA or formalin fixed samples were available). DNA probes capable of detecting rearrangement at both the major and the minor breakpoint regions were employed. We could detect t(14;18) in only 21 out of 51 cases (41%). However, a review of the literature showed that comparable results have been obtained previously using both cytogenetic and molecular biological techniques and our results support the view that the global incidence of t(14;18) in follicular lymphoma is no greater than 70%. Furthermore, this study has indicated that the PCR is a reliable method for identifying t(14;18) when only formalin-fixed paraffin-embedded tissue or degraded DNA is available.

Entities:  

Mesh:

Year:  1990        PMID: 2223649     DOI: 10.1111/j.1365-2141.1990.tb07836.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction.

Authors:  Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; Roger G Owen; Gareth J Morgan; Andrew S Jack
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

2.  Expression of the bcl-2 gene product in follicular lymphoma.

Authors:  P Gaulard; M F d'Agay; M Peuchmaur; N Brousse; C Gisselbrecht; P Solal-Celigny; J Diebold; D Y Mason
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

Review 3.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

4.  Molecular frequency of BCL2/JH t(14; 18) using PCR among Lebanese patients with follicular lymphoma: another piece of the geographical map revealed.

Authors:  Rami Mahfouz; Dina Shammaa; Ayman Tawil; Ghazi Zaatari
Journal:  Mol Biol Rep       Date:  2006-12-06       Impact factor: 2.316

5.  Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis: a method for the rapid molecular diagnosis of lymphoproliferative disorders applicable to fresh frozen and formalin-fixed, paraffin-embedded tissues, blood, and bone marrow aspirates.

Authors:  V S Meier; A Rufle; F Gudat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  bcl-2 protein in invasive ductal breast carcinomas.

Authors:  J Hurlimann; B Larrinaga; D L Vala
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Bcl-2 protein expression and long-term survival in breast cancer.

Authors:  H Joensuu; L Pylkkänen; S Toikkanen
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status.

Authors:  C Doglioni; A P Dei Tos; L Laurino; C Chiarelli; M Barbareschi; G Viale
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Prognostic implications of p53 and bcl-2 expression in 108 women with stage two breast cancer.

Authors:  R McLaughlin; D O'Hanlon; T McHale; C E Connolly; H F Given
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

10.  Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma.

Authors:  F Pezzella; M Jones; E Ralfkiaer; J Ersbøll; K C Gatter; D Y Mason
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.